Skip to content

Recurrent Crying Spells in Cerebral Palsy

Recurrent Crying Spells in Cerebral Palsy With Spastic Quadriparesis - A Crossover Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955655
Acronym
RCSCPSQ
Enrollment
70
Registered
2013-10-07
Start date
2005-12-31
Completion date
2013-08-31
Last updated
2013-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Crying Spells

Keywords

Baclofen, cerebral palsy, colic, crying infant, recurrent crying spells, spasticity, therapy

Brief summary

This is a study of recurrent crying spells in Spastic Cerebral Palsy patients and their treatment.

Detailed description

This is the first study of recurrent crying spells in Cerebral Palsy with Spastic quadriparesis depicting the diagnostic criteria and treatment.

Interventions

DRUGBaclofen

Since the therapeutic window of Baclofen is narrow, the lowest dose compatible with an optimal response was used.

OTHERPlacebo

Sponsors

Sathbhavana Brain Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* Recurrent Crying Spells in Cerebral Palsy with Spastic Quadriparesis. * Age range 0-12 years.

Exclusion criteria

* Crying due to known causes (like hunger, sleep, food intolerance etc.), * Crying that responded to routine management (changes in food or feeding techniques, anticolic, analgesics), * Fever of ≥100.4ºF (38ºC), * The infant refuses to eat or drink for more than a few hours, vomits excessively, has bloody stools, or has a change in behavior (lethargy or decreased responsiveness). * Colic * Worst ever crying occurring for the first time * Respiratory, renal and hepatic diseases, * Progressive encephalopathies, * Received Baclofen in the previous 30 days

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline cry duration in seconds over a 10-day period while on placebo.11th to 20th day and 51st day to 60th dayCry duration in seconds over a 10-day period while on placebo was compared to that of Baclofen.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026